Imaging can also aid in distinguishing primary cutaneous MCC from cutaneous metastases of noncutaneous neuroendocrine carcinomas, such as SCLC, particularly in cases where immunohistochemical markers are atypical (e.g., CK20-negative and/or TTF-1–positive). Here, TTF1 is linked to small cell lung carcinoma.